Revmab Biosciences Usa

RevMAb Biosciences is biotechnology company that focuses on the developing of goat and rabbit monoclonal antibodies.

Business Model:

Revenue: $19M

Employees: 51-200

Detailed Revmab Biosciences Usa Information

Geographic Data

Revmab Biosciences Usa headquarters map

Address: 870 Dubuque Ave

City: South San Francisco

State: CA

Zip: 94080

Country: US

Financial Info

Stage:

series unknown

Raised Last:

$2M

Raised Total:

$6M

Metrics

8,707,510Website Global Rank

293Website Monthly Traffic

Twitter Followers

Description

RevMAb Biosciences USA, Inc is a South San Francisco based biotechnology company focused on the development of Goat and Rabbit monoclonal antibodies, using a revolutionary technology that does not require cell fusion and hybridoma generation. Our mission is to promote personal health by accelerating biomedical research and advancing disease diagnosis by providing superior monoclonal antibodies.

Contact Phone:
+16503517327

Contact Email:

Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
9/2014 Equity $3.3M
4/2016 Venture Round $4.3M
8/2017 Equity $2.3M
2/2018 Venture Round $2.3M
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research